In a further sign that Abingdon’s pipeline is maturing, it has today announced a significant contract win with a European partner for the manufacture of lateral flow device components for a Covid-19 antigen test. It is worth a minimum of £2.7m over the initial 12 month period, with scope to extend the duration, scale and scope of the contract. As such, we believe it has the potential to be materially larger than this over time. In our view, this is a strong endorsement of Abingdon’s range of cap ....
17 May 2022
Pipeline firming up with contract win worth min £2.7m
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Pipeline firming up with contract win worth min £2.7m
Abingdon Health PLC (ABDX:LON) | 10.5 0 0.0% | Mkt Cap: 12.8m
- Published:
17 May 2022 -
Author:
Chris Glasper -
Pages:
3
In a further sign that Abingdon’s pipeline is maturing, it has today announced a significant contract win with a European partner for the manufacture of lateral flow device components for a Covid-19 antigen test. It is worth a minimum of £2.7m over the initial 12 month period, with scope to extend the duration, scale and scope of the contract. As such, we believe it has the potential to be materially larger than this over time. In our view, this is a strong endorsement of Abingdon’s range of cap ....